Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
- 30 September 2010
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 136 (3), 409-418
- https://doi.org/10.1016/j.clim.2010.04.011
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory diseaseProceedings of the National Academy of Sciences of the United States of America, 2007
- Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome)Pediatric Allergy and Immunology, 2006
- Presenting phenotype in 100 children with the 22q11 deletion syndromeEuropean Journal of Pediatrics, 2004
- T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndromeBlood, 2004
- CD4 + CD25 + T-Cell Production in Healthy Humans and in Patients with Thymic HypoplasiaClinical and Vaccine Immunology, 2002
- Graves' disease in patients with 22q11.2 deletionThe Journal of Pediatrics, 2001
- Humoral immunity in DiGeorge syndromeThe Journal of Pediatrics, 1995
- Hypogammaglobulinaemia in Digeorge sequenceEuropean Journal of Pediatrics, 1989
- Prediction of persistent immunodeficiency in the DiGeorge anomalyThe Journal of Pediatrics, 1989
- The spectrum of the DiGeorge syndromeThe Journal of Pediatrics, 1979